Australia markets closed

RGEN May 2024 130.000 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
0.97000.0000 (0.00%)
As of 12:59PM EDT. Market open.
Full screen
Previous close0.9700
Open0.9700
Bid0.0000
Ask0.0000
Strike130.00
Expiry date2024-05-17
Day's range0.9700 - 0.9700
Contract rangeN/A
Volume2
Open interest8
  • GlobeNewswire

    Repligen to Report First Quarter 2024 Financial Results

    Webcast and Conference Call to Be Held Wednesday, May 1, 2024, at 8:30 a.m. ETWALTHAM, Mass., April 17, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its first quarter 2024 financial results on Wednesday, May 1, 2024. The Company will issue a press release before the market opens and will host a conference call at 8:30 a.m. ET to discuss business updates and financial results for the three- month reporting period ended March 31, 2024. Th

  • Insider Monkey

    Artisan Mid Cap Fund Trimmed Repligen Corporation (RGEN) after Share Appreciation

    Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here. In the first quarter, the fund’s Investor Class fund ARTMX returned 10.41%, Advisor Class fund APDMX posted a return of 10.40%, and Institutional Class fund APHMX returned 10.44%, compared […]

  • GlobeNewswire

    Repligen Appoints Maggie A. Pax to Board of Directors

    WALTHAM, Mass., March 19, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced the appointment to its Board of Directors of life sciences industry executive Maggie A. Pax. This appointment expands the size of Repligen’s board from eight to nine members. Ms. Pax brings to Repligen over 25 years of experience leading the development and execution of growth strategies for global companies. This includes eight years with Thermo Fisher Scientific, where, from 2016–2020, she ser